ANL

Adlai Nortye Ltd.

Phase 1 AI-extracted

AN9025

RAS-addicted tumors

Date

TBD

Phase 1 readout · Date TBD estimated

What's at stake Phase 1 trial results for AN9025 in RAS-addicted tumors are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 6-K verified 12h ago

“Ph1 dose escalation completion in H1 2027 Ex-China1”

Add to calendar Post on X Reddit

Provenance

1 source on file.

SEC 6-K — verified 12h ago

Link copied ✓